BCRXCongressional Stock Trades
BioCryst Pharmaceuticals Inc
Biological Products, (No Diagnostic Substances)
Congressional stock trades in BioCryst Pharmaceuticals Inc (BCRX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
1
Last Traded
Jul 10, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Sep 4, 2026 | Jul 10, 2026 | Buy | $1,001 - $15,000 | -16.94% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 13, 2025 | Buy | $1,001 - $15,000 | +25.80% |
Price History
About BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.